Abstract:Marek's disease virus (MDV) is a highly contagious pathogen that causes neoplastic disease, named as Marek's disease (MD). Although it was first described as polyneuritis disease, MD also induces severe immunosuppression and tumors in infected chickens. Based on biological characteristics, MDV is classified into three serotypes. MDV-1 belonging to serotype 1, includes pathogenic strains and their derivatives. Serotype 2 (MDV-2) and 3 (MDV-2) are non-pathogenic strains, usually used as vaccines. Pathogenic MDV-1 is categorized into four pathotypes: Mild virulent (m), virulent (v), very virulent (vv), and very virulent plus (vv+). MD is the first neoplastic disease that has been successfully controlled by vaccine. By using vaccines, the morbidities and mortalities of chickens were significantly reduced in the farm. However, MDV continues to evolve, and more virulent strains have gradually been seen to break through vaccinal immunity, which results in outbreak of disease. In recent years, highly virulent strains have been isolated in the world, becoming a new threat for the control of MD.The natural route of MDV infection is through inhalation of airborne cell-free virus particles from the contaminated dust and dander. Once the virus is inhaled, lung epithelial cells and macrophages are speculated to be the primary target cells for MDV infection. Then the virus infects and amplifies in B cells of lymphoid organs (early cytolytic infection). Finally, T cells, mainly activated CD4(+) T cells are recruited to the lymphoid organs and become latently infected (latency, followed by late cytolytic infection) and therefore transformed (transformation). Reactivation (late cytolytic infection) describes the recurrence of cytolytic replication in response to intra- and/or extracellular stimuli. MDV encodes more than 100 genes. Among them, meq is an oncogenic gene that is unique to MDV-1 and consistently expressed in all MD lymphomas and cell lines. Deletion of the meq gene completely abrogates the tumorigenesis induced by virulent strains, however, still maintains the ability to induce lymphoid organ atrophy. The meq-deleted viral strain could not be used as vaccine even though possessing superior protection advantages. To overcome the disadvantage and improve the safety and usefulness of meqdeleted vaccine strain, in an earlier study, we generated a meq and lorf9 deletion mutant virus as a vaccine candidate. It is important to know if the double-gene deletion vaccine strain still maintains the ability of reactivation and amplification in late cytolytic infectious stage, which may cause more viruses shedding into the environment. To test this hypothesis, Realtime PCR technology was used for quantitative analysis, by detecting MDV-specific ICP4 and chicken OVO genes. Viral content was measured from splenocytes and feather follicle of 63-days old infected chickens. Standard curves were established in the first step, and then total DNA was extracted. CT values were obtained both for ICP4 and OVO genes. Viral copy number per lymphocyte was calculated using the standard curve. The results indicate that the double-gene deletion mutant virus showed significantly reduced replication during latent and reactivation stages. This will be the theoretical basis for further analysis of immunological mechanism induced by the double-gene deletion mutant virus.

Knockdown of the Meq Gene in Marek's Disease Tumor Cell Line MSB1 Might Induce Cell Apoptosis and Inhibit Cell Proliferation and Invasion

Gene Expression Profiling in rMd5- and rMd5Δmeq-Infected Chickens

Gene expression profiling in rMd5- and rMd5deltameq-infected chickens.

Gga-miR-219b targeting BCL11B suppresses proliferation, migration and invasion of Marek’s disease tumor cell MSB1

Meq And Lorf9 Deletion Significantly Reduced Capacity Of Replication Of Very Virulent Marek'S Disease Virus

Gene Expression Profiling in rMd5- and rMd5&Dgr;meq-Infected Chickens

Gga-Mir-140-3p Inhibit Proliferation, Migration and Invasion in MDV-transformed MSB1 Cells

MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer

Chicken Gga-Mir-103-3p Targets CCNE1 and TFDP2 and Inhibits MDCC-MSB1 Cell Migration

Gene expression analysis of host spleen responses to Marek's disease virus infection at late tumor transformation phase.

Efficient Cross-Screening and Characterization of Monoclonal Antibodies Against Marek's Disease Specific Meq Oncoprotein Using CRISPR/Cas9-Gene-Edited Viruses.

Lorf9 Deletion Significantly Eliminated Lymphoid Organ Atrophy Induced by Meq-Deleted Very Virulent Marek's Disease Virus.

Chicken gga-miR-103-3p Targets CCNE1 and TFDP2 and Inhibits MDCC-MSB1 Cell Migration.

Gga-miR-130b-3p Inhibits MSB1 Cell Proliferation, Migration, Invasion, and Its Downregulation in MD Tumor is Attributed to Hypermethylation.

Integrated Analysis of Methylation Profiles and Transcriptome of Marek's Disease Virus-Infected Chicken Spleens Reveal Hypomethylation of CD4 and HMGB1 Genes Might Promote Marek's Disease Tumorigenesis

Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line.

Marek's Disease Virus (<i>Gallid alphaherpesvirus</i> 2)-Encoded miR-M2-5p Simultaneously Promotes Cell Proliferation and Suppresses Apoptosis Through RBM24 and MYOD1-Mediated Signaling Pathways

P2-034: The molecular mechanism of Nm23-H1 gene transfection on reversing invasion and metastasis phenotype in human high-metastatic large cell lung cancer cell line L9981

Marek’s Disease Virus (Gallid alphaherpesvirus 2)-Encoded miR-M2-5p Simultaneously Promotes Cell Proliferation and Suppresses Apoptosis Through RBM24 and MYOD1-Mediated Signaling Pathways

Fully Attenuated Meq and Pp38 Double Gene Deletion Mutant Virus Confers Superior Immunological Protection Against Highly Virulent Marek’s Disease Virus Infection

Gga-miR-181a Modulates ANP32A Expression and Inhibits MDCC-MSB-1 Cell